Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations

DMD gene mutations have been associated with the development of Dystrophinopathies. Interestingly, it has been recently reported that DMD is involved in the development and progression of myogenic tumors, assigning DMD a tumor suppressor activity in these types of cancer. However, there are only few...

Descripción completa

Detalles Bibliográficos
Autores principales: Luce, Leonela N., Abbate, Mercedes, Cotignola, Javier, Giliberto, Florencia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352069/
https://www.ncbi.nlm.nih.gov/pubmed/27391342
http://dx.doi.org/10.18632/oncotarget.10426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352069/
https://www.ncbi.nlm.nih.gov/pubmed/27391342
http://dx.doi.org/10.18632/oncotarget.10426

Ejemplares similares